Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 165,357 |
|
|||||
| News | - | ||||||
| Day High | 1.51 | Low High |
|||||
| Day Low | 1.42 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Spero Therapeutics Inc | SPRO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.06 | 4.20% | 1.49 | 17:04:29 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.44 | 1.42 | 1.51 | 1.46 | 1.43 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 543 | 165,357 | US$ 1.46 | US$ 241,366 | - | 0.99 - 1.995 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:15:47 | 66 | US$ 1.51 | USD |
Spero Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 78.65M | 53.87M | - | 103.78M | 22.81M | 0.42 | 3.45 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spero Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.48 | 1.54 | 1.37 | 1.41 | 216,634 | 0.01 | 0.68% |
| 1 Month | 1.70 | 1.81 | 1.37 | 1.60 | 230,690 | -0.21 | -12.35% |
| 3 Months | 1.36 | 1.89 | 1.33 | 1.66 | 336,770 | 0.13 | 9.56% |
| 6 Months | 0.99 | 1.89 | 0.99 | 1.53 | 248,898 | 0.50 | 50.51% |
| 1 Year | 1.69 | 1.995 | 0.99 | 1.52 | 273,876 | -0.20 | -11.83% |
| 3 Years | 13.58 | 19.87 | 0.6801 | 2.36 | 959,954 | -12.09 | -89.03% |
| 5 Years | 12.22 | 23.639 | 0.6801 | 3.56 | 641,752 | -10.73 | -87.81% |
Spero Therapeutics Description
| Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital. |
